Recurrent Non-Hodgkin’s Lymphoma

Veltuzumab Effective for Refractory Non-Hodgkin’s Lymphoma (07-29-2009)

Veltuzumab is safe and effective for patients with relapsed/refractory B-cell non-Hodgkin’s lymphoma, according to the results of a study published in the Journal of Clinical Oncology.[1] Non-Hodgkin’s lymphoma (NHL) is a form of cancer that begins... Continue Reading

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology (03-8-2009)

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology The 2008 ASH meeting featured several reports of new agents that are showing promise in the treatment of Non-Hodgkin’s... Continue Reading

Zevalin® Effective for Patients with Follicular Lymphoma Following an Autologous Transplant (03-8-2009)

Zevalin® Effective for Patients with Follicular Lymphoma Following an Autologous Transplant Zevalin® (Yttrium-90 [(90)Y] ibritumomab tiuxetan) appears to provide effective, long-term anticancer responses for patients with follicular lymphoma whose cancer... Continue Reading

Zevalin® Effective for Treatment of Cutaneous B-Cell Lymphoma (03-8-2009)

Zevalin® Effective for Treatment of Cutaneous B-Cell Lymphoma Zevalin® (Yttrium-90 [(90)Y] ibritumomab tiuxetan) appears highly effective in the treatment of primary cutaneous B-cell lymphoma (PCBCL). The details of this study appeared in an early online... Continue Reading

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma (03-8-2009)

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma Statins may reduce the effectiveness of Rituxan® (rituximab) in treatment of non-Hodgkin’s lymphoma (NHL), according to a recently published article in PLoS Med (the... Continue Reading

Stem Cell Transplant May Improve Survival Among Elderly with Relapsed Non-Hodgkin’s Lymphoma (03-8-2009)

Stem Cell Transplant May Improve Survival Among Elderly with Relapsed Non-Hodgkin’s Lymphoma A recent study reveals that elderly patients with relapsed non-Hodgkin’s Lymphoma (NHL) may benefit from autologous stem cell transplant. Results... Continue Reading

Non-Hodgkin’s Lymphoma Survivors May Suffer Symptoms of Post Traumatic Stress (03-8-2009)

Non-Hodgkin’s Lymphoma Survivors May Suffer Symptoms of Post Traumatic Stress Patients who have been diagnosed and treated for non-Hodgkin’s lymphoma may have symptoms of post traumatic stress disorder (PTSD). These finding were recently published... Continue Reading

Treanda® Approved for Recurrent NHL (11-3-2008)

Treanda® Approved for Recurrent NHL The United States Food and Drug Administration has approved Treanda® (bendamustine hydrochloride) for the treatment of slow-growing (indolent) B-cell non-Hodgkin’s lymphoma (NHL) that has progressed either during... Continue Reading

« Previous Page